Administration of angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II type-I Receptor Blockers (ARBs), and thiazolidinediones (TZDs) to control hyperglycemia is related to increased expression of ACE2 receptor [20]. This evidence concerns the gene ACE and Hyperglycemia.